Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-08

FDA Approved: ZONISAMIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Zonisamide from Aurobindo Pharma Limited (ANDA077645). The approval pertains to changes to the generic product's lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

SUPPL AP for ZONISAMIDE (ZONISAMIDE)